Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

12 Months Ended

Nov. 30, 2013

Significant Option Groups Outstanding and Exercisable Option and its Price and Contractual Life

Significant option groups outstanding and exercisable at November 30, 2013 and related price and contractual life information are as follows:


		Outstanding						Exercisable
Range of Exercise Prices		Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price
$	0.42 to $1.00		7,500		1.40	$	.78		7,500	$	.78
$	1.01 to $ 2.00		531,759		6.94	$	1.70		513,424	$	1.70
$	2.01 to $ 3.00		573,001		5.97	$	2.50		482,184	$	2.54

			1,112,260		6.40	$	2.11		1,003,108	$	2.09

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested shares as of November 30, 2013, and changes during the fiscal year then ended, is presented below:


	Options			Weighted Average Grant-Date Fair Value

Non-vested at November 30, 2012		251,403		$	1.77

Granted		36,000			1.58
Vested		(145,756	)		1.68
Forfeited		(32,495	)		1.89

Non-vested at November 30, 2013		109,152		$	1.79

Service-Based Vesting Condition Options [Member]

Fair Value of Options Granted

Variables used to determine the fair value of the options granted for the years ended November 30, 2013 and November 30, 2012 are as follows:


	2013			2012
Weighted average values:
Expected dividends		0	%		0	%
Expected volatility		111	%		113	%
Risk free interest rate		1.15	%		.87	%
Expected life		5.0 years			5.5 years

Stock Option Activity for Options

Stock option activity for options with only service-based vesting conditions for the year ended November 30, 2013, was as follows:


	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value

Outstanding at November 30, 2012		1,183,098		$	2.15		7.12	$	580,730

Granted		36,000			2.00				—
Exercised		(10,000	)		1.50				5,575
Expired/forfeited		(96,838	)		2.63				7,650


Outstanding at November 30, 2013		1,112,260		$	2.11		6.40	$	88,614

Exercisable at November 30, 2013		1,003,108		$	2.09		6.51	$	88,531

Performance and Market-Based Vesting Condition Options [Member]

Fair Value of Options Granted

Variables used to determine the fair value of options with performance-based and market-based vesting conditions granted during the fiscal year ended November 30, 2012 are as follows:


Weighted average values:
Expected dividends	0	%
Expected volatility	107.03	%
Risk free interest rate	1.00	%
Expected life	6.4 years

Stock Option Activity for Options

Stock option activity for options with performance-based and market-based vesting conditions for the fiscal year ended November 30, 2013, was as follows:


	Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value

Outstanding at November 30, 2012		640,000	$	1.74		8.83	$	511,600

Granted		—		—
Exercised		—		—
Expired/forfeited		—		—


Outstanding at November 30, 2013		640,000	$	1.74		7.83	$	70,000

Exercisable at November 30, 2013		—		—		—		—